Amyotrophic Lateral Sclerosis
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Enrichment of rare protein-altering CCNF variants was evident in a large sporadic ALS replication cohort.
|
27080313 |
2016 |
Amyotrophic Lateral Sclerosis
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Our result indicates that the mutation of CCNF is rare in patients with ALS and FTD from Mainland China.
|
28281833 |
2017 |
Amyotrophic Lateral Sclerosis
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Mutational analyses of the CCNF gene were performed using Sanger sequencing in a cohort of 255 unrelated patients with ALS.
|
29102476 |
2018 |
Amyotrophic Lateral Sclerosis
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
This is the first report of an ALS-linked CCNF mutation in vivo and taken together with the in vitro model identifies the disruption of cell death pathways as a significant consequence of this mutation.
|
28444311 |
2017 |
Amyotrophic Lateral Sclerosis
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
This is the first reported reprogramming of cells with a mutation in the cyclin F gene, and represents a novel resource for the study of amyotrophic lateral sclerosis.
|
31445393 |
2019 |
Amyotrophic Lateral Sclerosis
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
In this study, we examined the ALS/FTD-causing p.Ser621Gly (p.S621G) mutation in cyclin F and its effect upon downstream Lys48-specific ubiquitylation in transfected Neuro-2A and SH-SY5Y cells.
|
28852778 |
2018 |
Red cell distribution width determination
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
RDW - Red blood cell distribution width result
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Frontotemporal dementia
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Interrogation of international cohorts identified additional novel CCNF variants in familial and sporadic ALS and FTD.
|
27080313 |
2016 |
Frontotemporal dementia
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
In this study, we examined the ALS/FTD-causing p.Ser621Gly (p.S621G) mutation in cyclin F and its effect upon downstream Lys48-specific ubiquitylation in transfected Neuro-2A and SH-SY5Y cells.
|
28852778 |
2018 |
Frontotemporal dementia
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Our result indicates that the mutation of CCNF is rare in patients with ALS and FTD from Mainland China.
|
28281833 |
2017 |
Pick Disease of the Brain
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.
|
27080313 |
2016 |
Pick Disease of the Brain
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations of CCNF gene is rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia from Mainland China.
|
28281833 |
2017 |
Polycystic Kidney Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1).
|
7896286 |
1994 |
African Burkitt's lymphoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Recurrent mutations in two genes not previously associated with eBL were identified in 20% of tumors: RHOA and cyclin F (CCNF).
|
26468873 |
2015 |
Familial (FPAH)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Interrogation of international cohorts identified additional novel CCNF variants in familial and sporadic ALS and FTD.
|
27080313 |
2016 |
POLYCYSTIC KIDNEY DISEASE 1
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1).
|
7896286 |
1994 |
Amyotrophic Lateral Sclerosis
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
Liver carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
|
28284560 |
2017 |
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dyspnea
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Fatigue
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Laryngospasm
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Spasticity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|